Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Stemcentrx, Inc. patents

List of Stemcentrx, Inc. patents

List of Riot Games patents

List of ELTRON RESEARCH & DEVELOPMENT, INCORPORATED patents

List of Nippon Kayaku patents

List of SBIR/STTR awards granted to Quantum Magnetics, Inc.

List of funding rounds for Growlife

Patents where

Current Assignee

Name

is

‌

Stemcentrx, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9353182 Anti-DLL3 antibodies	Patent 9353182 was granted and assigned to Stemcentrx, Inc. on May, 2016 by the United States Patent and Trademark Office.	‌ Stemcentrx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9353182	May 31, 2016
	‌ US Patent 9334318 Multivalent DLL3 antibodies	Patent 9334318 was granted and assigned to Stemcentrx, Inc. on May, 2016 by the United States Patent and Trademark Office.	‌ Stemcentrx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9334318	May 10, 2016
	‌ US Patent 9133271 Anti-DLL3 antibody drug conjugates and methods of use	Patent 9133271 was granted and assigned to Stemcentrx, Inc. on September, 2015 by the United States Patent and Trademark Office.	‌ Stemcentrx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9133271	September 15, 2015
	‌ US Patent 9089615 Anti-DLL3 antibodies	Patent 9089615 was granted and assigned to Stemcentrx, Inc. on July, 2015 by the United States Patent and Trademark Office.	‌ Stem CentRx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9089615	July 28, 2015
	‌ US Patent 9155803 Anti-DLL3 antibody drug conjugates and methods of use	Patent 9155803 was granted and assigned to Stemcentrx, Inc. on October, 2015 by the United States Patent and Trademark Office.	‌ Stemcentrx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9155803	October 13, 2015
	‌ US Patent 9358304 Methods of making DLL3 antibody drug conjugates	Patent 9358304 was granted and assigned to Stemcentrx, Inc. on June, 2016 by the United States Patent and Trademark Office.	‌ Stemcentrx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9358304	June 7, 2016
	‌ US Patent 9089616 Anti-DLL3 antibody drug conjugates and methods of use	Patent 9089616 was granted and assigned to Stemcentrx, Inc. on July, 2015 by the United States Patent and Trademark Office.	‌ Stem CentRx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9089616	July 28, 2015
	‌ US Patent 9352051 Kits containing DLL3 antibody drug conjugates	Patent 9352051 was granted and assigned to Stemcentrx, Inc. on May, 2016 by the United States Patent and Trademark Office.	‌ Stemcentrx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9352051	May 31, 2016
	‌ US Patent 9089617 Anti-DLL3 antibody drug conjugates	Patent 9089617 was granted and assigned to Stemcentrx, Inc. on July, 2015 by the United States Patent and Trademark Office.	‌ Stem CentRx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9089617	July 28, 2015
	‌ US Patent 9090683 Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies	Patent 9090683 was granted and assigned to Stemcentrx, Inc. on July, 2015 by the United States Patent and Trademark Office.	‌ Stem CentRx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9090683	July 28, 2015
	‌ US Patent 9107961 Anti-DLL3 antibody drug conjugates for treating cancer	Patent 9107961 was granted and assigned to Stemcentrx, Inc. on August, 2015 by the United States Patent and Trademark Office.	‌ Stem CentRx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9107961	August 18, 2015
	‌ US Patent 9345784 Methods of delivering DLL3 antibody drug conjugates	Patent 9345784 was granted and assigned to Stemcentrx, Inc. on May, 2016 by the United States Patent and Trademark Office.	‌ Stemcentrx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9345784	May 24, 2016
	‌ US Patent 9409995 PTK7 modulators and methods of use	Patent 9409995 was granted and assigned to Stemcentrx, Inc. on August, 2016 by the United States Patent and Trademark Office.		‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9409995	August 9, 2016
	‌ US Patent 9173959 Anti-DLL3 antibody drug conjugates	Patent 9173959 was granted and assigned to Stemcentrx, Inc. on November, 2015 by the United States Patent and Trademark Office.	‌ Stemcentrx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9173959	November 3, 2015
	‌ US Patent 9011854 Anti-DLL3 antibody drug conjugates and methods of use	Patent 9011854 was granted and assigned to Stemcentrx, Inc. on April, 2015 by the United States Patent and Trademark Office.	‌ Stem CentRx, Inc.	‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9011854	April 21, 2015
	‌ US Patent 9320812 Modulators and methods of use	Patent 9320812 was granted and assigned to Stemcentrx, Inc. on April, 2016 by the United States Patent and Trademark Office.		‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9320812	April 26, 2016
	‌ US Patent 9458231 Modulators and methods of use	Patent 9458231 was granted and assigned to Stemcentrx, Inc. on October, 2016 by the United States Patent and Trademark Office.		‌ Stemcentrx, Inc.		United States Patent and Trademark Office	9458231	October 4, 2016

17 results

0 selected

17 results

0 selected